These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 36092755)

  • 41. Feasibility and outcomes of percutaneous radiofrequency ablation for intrahepatic recurrent hepatocellular carcinoma after liver transplantation: a single-center experience.
    Liu B; Huang G; Xie X; Zhao Q; Su L; Liu M; Li X; Long J; Kuang M; Xie X
    Int J Hyperthermia; 2020; 37(1):1202-1209. PubMed ID: 33100042
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Surgical Resection versus Re-Ablation for Intrahepatic Recurrent Hepatocellular Carcinoma after Initial Ablation Therapy.
    Wang Y; Liao Y; Liu W; Zhang Y; Yuan Y; Qiu Y; Qiu J; Yang Z; He W; Wang C; Li K; Shi Y; Zuo D; Yuan Y; Li B
    Dig Surg; 2021; 38(1):46-57. PubMed ID: 33152739
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Survival outcomes of hepatectomy for stage B Hepatocellular carcinoma in the BCLC classification.
    Kamiyama T; Orimo T; Wakayama K; Shimada S; Nagatsu A; Yokoo H; Kamachi H; Yamashita K; Shimamura T; Taketomi A
    World J Surg Oncol; 2017 Aug; 15(1):156. PubMed ID: 28830473
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Anatomical Resection But Not Surgical Margin Width Influence Survival Following Resection for HCC, A Propensity Score Analysis.
    Lee JW; Lee YJ; Park KM; Hwang DW; Lee JH; Song KB
    World J Surg; 2016 Jun; 40(6):1429-39. PubMed ID: 26817652
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prognostic factors of recurrent intrahepatic cholangiocarcinoma after hepatectomy: A retrospective study.
    Yuan ZB; Fang HB; Feng QK; Li T; Li J
    World J Gastroenterol; 2022 Apr; 28(15):1574-1587. PubMed ID: 35582131
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Isolated complete caudate lobectomy with Glissonean pedicle isolation using Takasaki's technique and right-left approach: preliminary experience from two case reports.
    Nguyen HH; Nguyen TK; Le VD; Luong TH; Dang KK; Nguyen VQ; Trinh HS
    World J Surg Oncol; 2022 Feb; 20(1):31. PubMed ID: 35115011
    [TBL] [Abstract][Full Text] [Related]  

  • 47. TACE Combined with HIFU Versus Surgical Resection for Single Hepatocellular Carcinoma with Child-Pugh B Cirrhosis in Overall Survival and Progression-Free Survival: A Retrospective Study.
    Zhang Q; Wang Y; Zhang J; Zhang W; Gong J; Ma R
    Technol Cancer Res Treat; 2021; 20():15330338211060180. PubMed ID: 34855560
    [No Abstract]   [Full Text] [Related]  

  • 48. Intrahepatic recurrence after curative resection of hepatocellular carcinoma: long-term results of treatment and prognostic factors.
    Poon RT; Fan ST; Lo CM; Liu CL; Wong J
    Ann Surg; 1999 Feb; 229(2):216-22. PubMed ID: 10024103
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Infection with hepatitis C virus is an adverse prognostic factor after liver resection for early-stage hepatocellular carcinoma: implications for the management of hepatocellular carcinoma eligible for liver transplantation.
    Chirica M; Tranchart H; Tan V; Faron M; Balladur P; Paye F
    Ann Surg Oncol; 2013 Jul; 20(7):2405-12. PubMed ID: 23338483
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Volumetric parameters on FDG PET can predict early intrahepatic recurrence-free survival in patients with hepatocellular carcinoma after curative surgical resection.
    Lee JW; Hwang SH; Kim HJ; Kim D; Cho A; Yun M
    Eur J Nucl Med Mol Imaging; 2017 Nov; 44(12):1984-1994. PubMed ID: 28695236
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Clinicopathologic features and risk factors for extrahepatic recurrences of hepatocellular carcinoma after curative resection.
    Ochiai T; Ikoma H; Okamoto K; Kokuba Y; Sonoyama T; Otsuji E
    World J Surg; 2012 Jan; 36(1):136-43. PubMed ID: 22051887
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prognostic factors of disease-free and overall survival in patients with hepatocellular carcinoma undergoing partial hepatectomy in curative intent.
    Lurje G; Bednarsch J; Czigany Z; Amygdalos I; Meister F; Schöning W; Ulmer TF; Foerster M; Dejong C; Neumann UP
    Langenbecks Arch Surg; 2018 Nov; 403(7):851-861. PubMed ID: 30267147
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Salvage RFA in patients with intrahepatic recurrence after major hepatic surgery for colorectal cancer liver metastases: mid-term outcome.
    Zimmermann M; Pedersoli F; Schulze-Hagen M; Lurje G; Isfort P; Kuhl C; Bruners P
    Eur Radiol; 2020 Feb; 30(2):1221-1227. PubMed ID: 31493210
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Prognostic value of γ-glutamyl transpeptidase to albumin ratio combined with aspartate aminotransferase to lymphocyte ratio in patients with hepatocellular carcinoma after hepatectomy.
    Liu KJ; Lv YX; Niu YM; Bu Y
    Medicine (Baltimore); 2020 Nov; 99(48):e23339. PubMed ID: 33235099
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pulmonary metastasectomy for hepatocellular carcinoma.
    Chen YJ; Hsu HS; Hsieh CC; Wu YC; Wang LS; Hsu WH; Huang MH; Huang BS
    J Chin Med Assoc; 2004 Dec; 67(12):621-4. PubMed ID: 15779485
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Tumor size of hepatocellular carcinoma in noncirrhotic liver: a controversial predictive factor for outcome after resection.
    Truant S; Boleslawski E; Duhamel A; Bouras AF; Louvet A; Febvay C; Leteurtre E; Huet G; Zerbib P; Dharancy S; Hebbar M; Pruvot FR
    Eur J Surg Oncol; 2012 Dec; 38(12):1189-96. PubMed ID: 22863304
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Outcomes of Salvage Liver Transplantation and Re-resection/Radiofrequency Ablation for Intrahepatic Recurrent Hepatocellular Carcinoma: A New Surgical Strategy Based on Recurrence Pattern.
    Zhang X; Li C; Wen T; Peng W; Yan L; Yang J
    Dig Dis Sci; 2018 Feb; 63(2):502-514. PubMed ID: 29238896
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Nomograms predicting extra- and early intrahepatic recurrence after hepatic resection of hepatocellular carcinoma.
    Shinkawa H; Tanaka S; Takemura S; Amano R; Kimura K; Kinoshita M; Takahashi K; Matsuzaki S; Kubo S
    Surgery; 2021 Apr; 169(4):922-928. PubMed ID: 33190917
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Clinicopathological characteristics of patients with extrahepatic recurrence following a hepatectomy for hepatocellular carcinoma.
    Utsunomiya T; Shimada M; Shirabe K; Kajiyama K; Gion T; Takenaka K; Sugimachi K
    Hepatogastroenterology; 2001; 48(40):1088-93. PubMed ID: 11490807
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Benefit of adjuvant radiotherapy following narrow-margin hepatectomy in patients with intrahepatic cholangiocarcinoma that adhere to major vessels.
    Zheng X; Chen B; Wu JX; Jia AY; Rong WQ; Wang LM; Wu F; Zhao YT; Li YX; Wang WH
    Cancer Manag Res; 2018; 10():3973-3981. PubMed ID: 30310318
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.